Great week for Puma Biotechnology, Inc. (NASDAQ:PBYI) institutional investors after losing 32% over the previous year - Simply Wall St News
Why Shares in Puma Biotechnology Inc. Are Plunging | The Motley Fool
Puma Biotech's (PBYI) Nerlynx Aids Top Line, Overdependence a Woe
Breakeven On The Horizon For Puma Biotechnology, Inc. (NASDAQ:PBYI) | Nasdaq
These 2 Biotech Stocks Cratered in 2015 -- Is 1 Now a Buy? | The Motley Fool
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
SEC charges former Puma biotech exec with $1.1 million in insider trading
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Can Puma Biotechnology Inc (PBYI) Stock Rise to the Top of Healthcare Sector Tuesday?
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
PBYI | Puma Biotechnology Inc. Stock Overview (U.S.: Nasdaq) | Barron's
PBYI | Puma Biotechnology Stock Price
PBYI Stock Price and Chart — NASDAQ:PBYI — TradingView
Puma Biotechnology
2 Drug Stocks Near Key Technical Levels After ASCO
Puma's (PBYI) Earnings and Revenues Beat Estimates in Q1
Puma Biotech Stock Struggles To Find Its Footing In Crowded Oncology Space (NASDAQ:PBYI) | Seeking Alpha
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Puma Biotech Plunges on Sharp Drop in Cancer-Drug Sales - TheStreet
